ENDRA Life Sciences Inc. - NDRA
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Nov 26, 2025 | SCHEDULE 13D | — | 9.99% | — | View |
| Nov 14, 2025 | SCHEDULE 13G/A | L1 Capital Global Opportunities Master Fund, Ltd. | 3.0% | 35,589 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | S.H.N. Financial Investments Ltd. | 3.0% | 35,588 | View |
| Oct 30, 2025 | SCHEDULE 13G | John Carter Lipman | 9.99% | 115,477 | View |
| Oct 28, 2025 | SCHEDULE 13G | ATW Master Fund V LP | 9.9% | 116,024 | View |
| Oct 28, 2025 | SCHEDULE 13G | ATW Partners Opportunities Management, LLC | 9.9% | 116,024 | View |
| Oct 28, 2025 | SCHEDULE 13G | Kerry Propper | 9.9% | 116,024 | View |
| Oct 28, 2025 | SCHEDULE 13G | Antonio Ruiz-Gimenez | 9.9% | 116,024 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.